HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gene Microarray Analyses of Daboia russelli russelli Daboiatoxin Treatment of THP-1 Human Macrophages Infected with Burkholderia pseudomallei.

Abstract
Burkholderia pseudomallei is the causative agent of melioidosis and represents a potential bioterrorism threat. In this study, the transcriptomic responses of B. pseudomallei infection of a human macrophage cell model were investigated using whole-genome microarrays. Gene expression profiles were compared between infected THP-1 human monocytic leukemia cells with or without treatment with Daboia russelli russelli daboiatoxin (DRRDbTx) or ceftazidime (antibiotic control). Microarray analyses of infected and treated cells revealed differential upregulation of various inflammatory genes such as interleukin-1 (IL-1), IL-6, tumor necrosis factor-alpha (TNF-α), cyclooxygenase (COX-2), vascular endothelial growth factor (VEGF), chemokine C-X-C motif ligand 4 (CXCL4), transcription factor p65 (NF-kB); and several genes involved in immune and stress responses, cell cycle, and lipid metabolism. Moreover, following DRR-DbTx treatment of infected cells, there was enhanced expression of the tolllike receptor 2 (TLR-2) mediated signaling pathway involved in recognition and initiation of acute inflammatory responses. Importantly, we observed that highly inflammatory cytokine gene responses were similar in infected cells exposed to DRR-DbTx or ceftazidime after 24 h. Additionally, there were increased transcripts associated with cell death by caspase activation that can promote host tissue injury. In summary, the transcriptional responses during B. pseudomallei infection of macrophages highlight a broad range of innate immune mechanisms that are activated within 24 h post-infection. These data provide insights into the transcriptomic kinetics following DRR-DbTx treatment of human macrophages infected with B. pseudomallei.
AuthorsR Perumal Samy, J Manikandan, A Pachiappan, E E Ooi, L T Aw, B G Stiles, O L Franco, M Kandasamy, K M Mathi, G Rane, K S Siveen, C Arunachalam, M E Zayed, S A Alharbi, A P Kumar, G Sethi, L H K Lim, V T Chow
JournalCurrent molecular medicine (Curr Mol Med) Vol. 15 Issue 10 Pg. 961-74 ( 2015) ISSN: 1875-5666 [Electronic] Netherlands
PMID26592245 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • IL6 protein, human
  • Interleukin-1
  • Interleukin-6
  • NF-kappa B
  • Proteins
  • TLR2 protein, human
  • Toll-Like Receptor 2
  • Tumor Necrosis Factor-alpha
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Viper Venoms
  • daboiatoxin
  • Platelet Factor 4
  • Ceftazidime
  • Cyclooxygenase 2
  • PTGS2 protein, human
Topics
  • Animals
  • Burkholderia pseudomallei (drug effects, growth & development, ultrastructure)
  • Ceftazidime (pharmacology)
  • Cell Line
  • Cyclooxygenase 2 (genetics, metabolism)
  • Gene Expression Profiling
  • Gene Expression Regulation (drug effects)
  • Genome-Wide Association Study
  • Host-Pathogen Interactions
  • Humans
  • Interleukin-1 (genetics, metabolism)
  • Interleukin-6 (genetics, metabolism)
  • Macrophages (drug effects, metabolism, microbiology, ultrastructure)
  • Microarray Analysis
  • NF-kappa B (genetics, metabolism)
  • Platelet Factor 4 (genetics, metabolism)
  • Proteins (isolation & purification, pharmacology)
  • Signal Transduction
  • Toll-Like Receptor 2 (genetics, metabolism)
  • Transcriptome
  • Tumor Necrosis Factor-alpha (genetics, metabolism)
  • Vascular Endothelial Growth Factor A (genetics, metabolism)
  • Viper Venoms (chemistry)
  • Viperidae

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: